Abiopharma

Clinical trial NCT06192563 updates: 1. status: UNKNOWN → RECRUITING 2. completion date: 2026-01-31 → 2028-03-31 3. primary completion date: 2026-01-31 → 2028-03-31

Clinical trial NCT04195945 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-31 → 2026-05-20

Clinical trial NCT07037277: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06672445 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 36 → 39 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05945732 updates: 1. completion date: 2028-09-01 → 2030-12-31 2. primary completion date: 2028-09-01 → 2030-12-31 3. enrollment: 1155 → 2295 participants

Clinical trial NCT05683171 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 16 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07261085 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2026-02-26 3. primary completion date: 2026-03-30 → 2026-02-26

Clinical trial NCT07486934: start date: 2026-04-01 → 2026-05-14.

Clinical trial NCT05363488 updates: 1. start date: 2021-10-08 → 2019-05-01 2. completion date: 2021-10-08 → 2019-11-01 3. primary completion date: 2021-10-08 → 2019-11-01

Clinical trial NCT06075667 updates: 1. primary completion date: 2026-05-01 → 2026-06-02 2. enrollment: 150 → 160 participants 3. enrollment type: ESTIMATED → ACTUAL